There are currently 1290 clinical trials in Miami, Florida looking for participants to engage in research studies. Trials are conducted at various facilities, including University of Miami, GSK Investigational Site, University of Miami Miller School of Medicine-Sylvester Cancer Center and University of Miami Miller School of Medicine. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases
NCT05438212
Recruiting
This phase III trial compares the addition of stereotactic radiosurgery before or after surgery in treating patients with cancer that has spread to the brain (brain metastases). Stereotactic radiosurgery is a type of radiation therapy that delivers a high dose of radiation only to the small areas of cancer in the brain and avoids the surrounding normal brain tissue. Surgery and radiation may stop the tumor from growing for a few months or longer and may reduce symptoms of brain metastases.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/09/2024
Locations: University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida +1 locations
Conditions: Metastatic Malignant Neoplasm in the Brain
Register for Updates
IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma
NCT04109456
Recruiting
This is a phase Ib, open label clinical study to evaluate the safety, tolerability, PK and antitumor activities of IN10018 as monotherapy and in combination with cobimetinib in subjects with metastatic uveal melanoma and NRAS-mutant metastatic melanoma.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/08/2024
Locations: Sylvester Comprehensive Cancer Center., Miami, Florida
Conditions: Metastatic Melanoma
Register for Updates
Liver Cirrhosis Network Cohort Study
NCT05740358
Recruiting
Liver Cirrhosis Network (LCN) Cohort Study is an observational study designed to identify risk factors and develop prediction models for risk of decompensation in adults with liver cirrhosis. LCN Cohort Study involves multiple institutions and an anticipated 1200 participants. Enrolled participants will have study visits every 6 months (180 days), with opportunities to complete specific visit components via telehealth or remotely. Visits will include collection of questionnaire data and the in-p... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
01/05/2024
Locations: University of Miami Health System, Miami, Florida
Conditions: Cirrhosis, Cirrhosis, Liver, Cirrhosis Early, Cirrhosis Due to Hepatitis B, Cirrhosis Advanced, Cirrhosis Infectious, Cirrhosis Alcoholic, Cirrhosis, Biliary, Cirrhosis Cryptogenic, Cirrhosis Due to Hepatitis C, Cirrhosis Due to Primary Sclerosing Cholangitis
Register for Updates
IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's
NCT05543681
Recruiting
The purpose of this study is to assess the efficacy of an oral medication, IGC-AD1 that is a natural THC-based (Tetrahydrocannabinol) formulation, administered in micro doses, twice a day, on symptomatological Agitation, in patients with mild to severe dementia from Alzheimer's.
Gender:
All
Ages:
60 years and above
Trial Updated:
01/05/2024
Locations: Site 1200, Miami, Florida
Conditions: Alzheimer Disease, Agitation,Psychomotor, Depression, Anxiety, Memory Impairment, Care Giving Burden, NPS, Agitated; State, Acute Reaction to Stress, Aggression, Aggressive Outburst
Register for Updates
Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS
NCT03534323
Recruiting
This research study is assessing a new drug, duvelisib, in combination with a drug that is already FDA approved, venetoclax, as a possible treatment for participants with CLL or those with Richter's Syndrome
Gender:
All
Ages:
18 years and above
Trial Updated:
01/05/2024
Locations: University of Miami- Sylvester Comprehensive Cancer Center, Miami, Florida
Conditions: Chronic Lymphocytic Leukemia, Richter Syndrome
Register for Updates
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
NCT02915198
Recruiting
This research will help us to learn if the medicine called metformin reduces the risk of death, heart attacks, and/or strokes in patients who have pre-diabetes and heart or blood vessel problems.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/05/2024
Locations: Miami VA Healthcare System, Miami, FL, Miami, Florida
Conditions: Prediabetic State, Atherosclerosis, Metformin
Register for Updates
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
NCT05700149
Recruiting
International retrospective observational cohort study aimed to describe a molecular classification for NMZL.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/03/2024
Locations: University of Miami, Miami, Florida
Conditions: Nodal Marginal Zone Lymphoma
Register for Updates
Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events
NCT05224661
Recruiting
Prospective determination of the clinical utility of measurable residual disease (MRD) testing for relapse and survival of patients with acute myeloid leukemia (AML) undergoing allogeneic hematopoietic cell transplantation (alloHCT).
Gender:
All
Ages:
18 years and above
Trial Updated:
01/02/2024
Locations: University of Miami, Miami, Florida
Conditions: Acute Myeloid Leukemia in Remission
Register for Updates
Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis With Fibrosis
NCT05011305
Recruiting
Saroglitazar Magnesium for the Treatment of Nonalcoholic Steatohepatitis
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
12/30/2023
Locations: Zydus US034, Miami, Florida +2 locations
Conditions: Nonalcoholic Steatohepatitis, Fibrosis
Register for Updates
Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma
NCT02737046
Recruiting
The investigators propose to use Belinostat in combination with AZT as consolidation therapy for the treatment of ATLL.
Gender:
All
Ages:
18 years and above
Trial Updated:
12/29/2023
Locations: University of Miami, Miami, Florida
Conditions: Adult T-cell Leukemia-Lymphoma, ATLL
Register for Updates
Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease
NCT05534321
Recruiting
Early palliative care has been shown to improve the quality of life and even survival for patients with metastatic cancer. More and more supportive oncology teams in cancer centers now advocate for early integration of radiation therapy (RT) in a patient's palliative management course. While multiple randomized studies have evaluated the efficacy of different RT regimens in the treatment of symptomatic bone lesions, few studies have examined the impact of early, upfront RT for asymptomatic or mi... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
12/26/2023
Locations: Miami Cancer Institute at Baptist Health South Florida, Miami, Florida
Conditions: Spine Metastases
Register for Updates
Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis
NCT05554302
Recruiting
This study is for patients who have had surgery to remove brain metastasis and are planned to have stereotactic radiosurgery (SRS) after their brain surgery. It will be optional for patients to have a pre-surgery 18F-Fluciclovine PET/CT scan. The goal of the study is to determine whether a specific imaging agent, known as 18F-Fluciclovine, will help physicians evaluate the extent of surgery and determine if there is any visible tumor above what MRI alone can identify as well as improve the physi... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
12/26/2023
Locations: Miami Cancer Institute at Baptist Health South Florida, Miami, Florida
Conditions: Brain Metastases, Brain Cancer
Register for Updates